Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2008 (Vol. 28, No. 19)

The Cochlea Homepage

  • Educational content
  • Not tightly focused
Apparently, every single thing in the universe seems to have its own web page, and the cochlea of the inner ear is no exception. In fact, the ear may be the most interesting organ of the body. With its intricate yet delicate structures that facilitate the detection of physical changes resulting from sound waves, the ear is both host to the smallest bone in the body (stirrup) and the most complicated one (temporal bone). The cochlea, which is the subject of this page, is not covered as extensively as I would like. Most of the information at the page relates to the technical structures involved in the sense of hearing, and little is specific to the cochlea itself. The section on Cochlear Mechanics, though, will probably satisfy most junkies on the subject. Information is organized in a sort of tutorial fashion in which subsections within a section are organized as units that one clicks sequentially between. The figures explaining the principles range from simplistic to informative, so the site is a mixed bag. Overall, I’d give it a thumbs-up, but some may disagree.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »